Saptaparna Dasgupta, Bennett University Rituximab being a revolutionary monoclonal antibody, owing up to the mode of action as a potent therapeutic in targeting CD20 cells, has a strong impact on autoimmune health, including systemic lupus erythematosus. Thrombocytopenia, a rare illness, following rituximab is seen to give rise to haematological malignancy. As autoimmune disorders are rare […]
Prama Ghosh, Amity University Kolkata The current critical situation due to COVID–19 has resulted in excessive centralization of biomanufacturing capacities which is a matter of great concern. But on the brighter side, sharing of scientific data and information globally at an unprecedented speed has helped strengthen our ability in developing new solutions based on technology. […]
Prama Ghosh, Amity University Kolkata After the recovery of President Donald Trump from Covid-19 using a similar therapy as of the antibody medicine from AstraZeneca Plc, the company has started its late-stage trials for the same against COVID-19. The medicine will undergo two trials on more than 60000 people starting soon. Astra has also planned […]
Saptaparna Pal, Amity University Kolkata Head and neck squamous cell carcinoma are one of the most common neoplasias in the world. Most head and neck squamous cell carcinoma are treated as advanced disease and the multidisciplinary treatment strategies include radiotherapy (RT), chemotherapy (CT), surgery, and selected therapy. The addition of cetuximab, an IgGI chimeric monoclonal […]
Prama Ghosh, Amity University Kolkata The alarming hypothesis that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to be around for several years calls for rapid and successful therapies. Though anti-SARS-CoV-2 spike monoclonal antibodies originated from mice have shown robust performance in various immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, there is still a […]
-PRIYANKA CHAKRABORTY, AMITY UNIVERSITY, KOLKATA Lupus erythematosus, an autoimmune disease associated with inflammation affects the skin, kidney, heart, central nervous system, etc, and also produces antibodies that work against cellular nuclei of the body. Two patients suffering from lupus have been successfully treated by a monoclonal antibody, daratumumab. This monoclonal antibody targets specific plasma cells that […]
-Prama Ghosh, Amity University Kolkata Cancer Immunotherapy uses the immune system to eradicate cancer cells and prevent their spread in the body. It needs to be personalized because anticancer immune responses can be inhibited in various ways varying from person to person. There are pharmaceutical and non – pharmaceutical approaches cancer immunotherapy which includes monoclonal […]
